List of Excipients in API epoetin alfa-epbx
✉ Email this page to a colleague
Detailed excipient profiles for epoetin alfa-epbx
Excipient focus: CALCIUM CHLORIDE
epoetin alfa-epbx drug variants containing CALCIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | epoetin alfa-epbx | 0069-1305 |
| Vifor (International) Inc | epoetin alfa-epbx | 59353-002 |
| >Company | >Ingredient | >NDC |
epoetin alfa-epbx drug variants not containing CALCIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: GLUTAMIC ACID
epoetin alfa-epbx drug variants containing GLUTAMIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | epoetin alfa-epbx | 0069-1305 |
| Vifor (International) Inc | epoetin alfa-epbx | 59353-002 |
| >Company | >Ingredient | >NDC |
epoetin alfa-epbx drug variants not containing GLUTAMIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCINE
epoetin alfa-epbx drug variants containing GLYCINE
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | epoetin alfa-epbx | 0069-1305 |
| Vifor (International) Inc | epoetin alfa-epbx | 59353-002 |
| >Company | >Ingredient | >NDC |
epoetin alfa-epbx drug variants not containing GLYCINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROCHLORIC ACID
epoetin alfa-epbx drug variants containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | epoetin alfa-epbx | 0069-1305 |
| Vifor (International) Inc | epoetin alfa-epbx | 59353-002 |
| >Company | >Ingredient | >NDC |
epoetin alfa-epbx drug variants not containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: ISOLEUCINE
epoetin alfa-epbx drug variants containing ISOLEUCINE
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | epoetin alfa-epbx | 0069-1305 |
| Vifor (International) Inc | epoetin alfa-epbx | 59353-002 |
| >Company | >Ingredient | >NDC |
epoetin alfa-epbx drug variants not containing ISOLEUCINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: LEUCINE
epoetin alfa-epbx drug variants containing LEUCINE
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | epoetin alfa-epbx | 0069-1305 |
| Vifor (International) Inc | epoetin alfa-epbx | 59353-002 |
| >Company | >Ingredient | >NDC |
epoetin alfa-epbx drug variants not containing LEUCINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PHENYLALANINE
epoetin alfa-epbx drug variants containing PHENYLALANINE
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | epoetin alfa-epbx | 0069-1305 |
| Vifor (International) Inc | epoetin alfa-epbx | 59353-002 |
| >Company | >Ingredient | >NDC |
epoetin alfa-epbx drug variants not containing PHENYLALANINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 20
epoetin alfa-epbx drug variants containing POLYSORBATE 20
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | epoetin alfa-epbx | 0069-1305 |
| Vifor (International) Inc | epoetin alfa-epbx | 59353-002 |
| >Company | >Ingredient | >NDC |
epoetin alfa-epbx drug variants not containing POLYSORBATE 20
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM CHLORIDE
epoetin alfa-epbx drug variants containing SODIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | epoetin alfa-epbx | 0069-1305 |
| Vifor (International) Inc | epoetin alfa-epbx | 59353-002 |
| >Company | >Ingredient | >NDC |
epoetin alfa-epbx drug variants not containing SODIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
epoetin alfa-epbx drug variants containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | epoetin alfa-epbx | 0069-1305 |
| Vifor (International) Inc | epoetin alfa-epbx | 59353-002 |
| >Company | >Ingredient | >NDC |
epoetin alfa-epbx drug variants not containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
epoetin alfa-epbx drug variants containing SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | epoetin alfa-epbx | 0069-1305 |
| Vifor (International) Inc | epoetin alfa-epbx | 59353-002 |
| >Company | >Ingredient | >NDC |
epoetin alfa-epbx drug variants not containing SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
epoetin alfa-epbx drug variants containing SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | epoetin alfa-epbx | 0069-1305 |
| Vifor (International) Inc | epoetin alfa-epbx | 59353-002 |
| >Company | >Ingredient | >NDC |
epoetin alfa-epbx drug variants not containing SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: THREONINE
epoetin alfa-epbx drug variants containing THREONINE
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | epoetin alfa-epbx | 0069-1305 |
| Vifor (International) Inc | epoetin alfa-epbx | 59353-002 |
| >Company | >Ingredient | >NDC |
epoetin alfa-epbx drug variants not containing THREONINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
epoetin alfa-epbx drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | epoetin alfa-epbx | 0069-1305 |
| Vifor (International) Inc | epoetin alfa-epbx | 59353-002 |
| >Company | >Ingredient | >NDC |
epoetin alfa-epbx drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
